Kara N. Maxwell, MD, PhD, discusses the risk of cancer for males carrying BRCA mutations.
Kara N. Maxwell, MD, PhD
Advertisement
Articles by Kara N. Maxwell, MD, PhD
Kara N. Maxwell, MD, PhD, discusses key takeaways from a real-world investigation of germline mutation rates in patients with metastatic prostate cancer.
Kara N. Maxwell, MD, PhD, discusses the accessibility of genetic testing in the community setting for patients with metastatic prostate cancer.
Kara N. Maxwell, MD, PhD, discusses strategies to optimize the utility of genetic testing to better inform decision-making in prostate cancer treatment.
Kara Maxwell, MD, PhD discusses a study of genetic testing results in metastatic prostate cancer.
Advertisement
Latest Updated Articles
Dr Maxwell on Cancer Risk for Males Carrying Germline BRCA MutationsPublished: August 9th 2024 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5